deltatrials
Terminated PHASE3 INTERVENTIONAL 3-arm NCT00658645

Efficacy of Bifeprunox in Patients With Schizophrenia

A Multinational, Randomised, Double-blind, Fixed-dose, Bifeprunox Study Combining a 12-Week Placebo-controlled, Quetiapine-referenced Phase With a 12-month Quetiapine-controlled Phase in Patients With Schizophrenia

Sponsor: H. Lundbeck A/S

Conditions Schizophrenia
Updated 6 times since 2017 Last updated: Sep 24, 2010 Started: Mar 31, 2008 Primary completion: Aug 31, 2009 Completion: Nov 30, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Interim analysis showed inadequate efficacy of bifeprunox

A PHASE3 clinical study on Schizophrenia, this trial is terminated or withdrawn. The trial is conducted by H. Lundbeck A/S and has accumulated 6 data snapshots since 2008. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 12 months · monthly snapshotTerminated

Change History

6 versions recorded
  1. Sep 2025 — Present [monthly]

    Terminated PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

Show 1 earlier version
  1. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE3

    First recorded

Mar 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • H. Lundbeck A/S
Data source: H. Lundbeck A/S

For direct contact, visit the study record on ClinicalTrials.gov .